aod9604 vs frag 176191 HGH 176-191 vs. AOD9604: Understanding the Differences Buy Fragment 176-191 5 mg

In the ATTAIN-2 trial (participants with obesity and type 2 diabetes), GI adverse event rates were somewhat higher than in ATTAIN-1: nausea 20.1-36.4% versus 8.4% with placebo, vomiting 12.8-23.1% versus 3.8%, diarrhea 21.3-27.4% versus 15.0%, and constipation 17.7-22.4% versus 7.8%

Also in NK-T lymphoma, CD38 expression on tumor cells is significantly correlated with a poor survival for patients with nasal type of NK-T cell lymphoma [21]

United States (FDA and DSHEA) Not FDA-approved for weight loss or fat-burning claims AOD9604 was previously investigated as a potential obesity treatment, but the FDA has not approved it as a prescription medication (FDA PCAC briefing)

All products on this site are for research and development use only